ISOLYTE Drug Patent Profile

When do Isolyte patents expire, and when can generic versions of Isolyte launch?

Isolyte is a drug marketed by B Braun and is included in eighteen NDAs.

The generic ingredient in ISOLYTE is magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium acetate; sodium chloride; sodium gluconate; sodium phosphate, dibasic, heptahydrate. There are one hundred and forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium acetate; sodium chloride; sodium gluconate; sodium phosphate, dibasic, heptahydrate profile page.

Summary for ISOLYTE

US Patents:	0
Applicants:	1
NDAs:	18
DailyMed Link:	ISOLYTE at DailyMed

US Patents and Regulatory Information for ISOLYTE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER	calcium chloride; dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate	INJECTABLE;INJECTION	019867-001	Dec 20, 1993		DISCN	No	No
B Braun	ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	018274-001	Approved Prior to Jan 1, 1982		DISCN	No	No
B Braun	ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; potassium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride	INJECTABLE;INJECTION	019870-001	Jun 10, 1993		DISCN	No	No
B Braun	ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER	calcium chloride; dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate	INJECTABLE;INJECTION	018269-002	Jan 17, 1983		DISCN	No	No